logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Momenta Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 121

% Expired Patents = 14.0



Trademarks = 5

Forward Citations = 766

Loading Chart...
Loading Chart...

133 inventors (with patents filed for the assignee):

goldMedal Carlos J Bosques (35 out of 46 patents)

silverMedal Zachary Shriver (25 out of 85 patents)

bronzeMedal Jonathan C Lansing (16 out of 19 patents)

4.  Nur Sibel Gunay (16 out of 17 patents)

5.  Leona E Ling (15 out of 16 patents)

6.  James Meador, Iii (14 out of 15 patents)

7.  Nathaniel J Washburn (14 out of 15 patents)

8.  Sucharita Roy (12 out of 12 patents)

9.  Holly Prentice (12 out of 15 patents)

10.  Brian Edward Collins (12 out of 12 patents)

11.  Ian Christopher Parsons (12 out of 12 patents)

12.  Xiangping Zhu (11 out of 11 patents)

13.  Corinne Bauer (11 out of 11 patents)

14.  Ishan Capila (11 out of 17 patents)

15.  Yanjie Jiang (10 out of 10 patents)


Core Competencies:
Cell Culture
Glycoproteins
FcRn Antibodies
Engineered Fc Constructs
Neurodegeneration
Therapeutic Proteins
Chromatographic Methods
Polysaccharide Compositions
Amino Acid Analysis
Sialylated Glycoproteins
Modified Glycans
Hair Growth

121 patents:

1. 12723087 - ANTI-FCRN ANTIBODIES AND METHODS FOR TREATING MYASTHENIA GRAVIS (2026-09-01),
2. 12655209 - FcRn Antibodies and Methods of Use Thereof (2026-06-16),
3. 12595454 - METHODS OF CONTINUOUS CELL CULTURE (2026-04-07),
4. 12559542 - GLYCOPROTEINS WITH ANTI-INFLAMMATORY PROPERTIES (2026-02-24),
5. 12528867 - FCRN ANTIBODY COMPOSITIONS (2026-01-20),
6. 12460006 - Antibodies against integrin alpha 11 beta 1 (2025-11-04),
7. 12391759 - Methods related to engineered Fc constructs (2025-08-19),
8. 12360119 - Methods related to biologics (2025-07-15),
9. 12304950 - Methods of producing ustekinumab (2025-05-20),
10. 12297291 - Compositions and methods related to engineered Fc constructs (2025-05-13),
11. 12297256 - Methods for the treatment of neurodegeneration (2025-05-13),
12. 12163951 - Methods for predicting response to treatment (2024-12-10),
13. 12139735 - Cell culture process (2024-11-12),
14. 12071482 - Compositions and methods related to engineered Fc constructs (2024-08-27),
15. 11827682 - Engineered Fc constructs (2023-11-28),
Company Overview
Momenta Pharmaceuticals, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of biologics. The company focuses on innovative therapeutic proteins, particularly in the areas of neurodegeneration and autoimmune diseases. Momenta's expertise encompasses advanced technologies such as cell culture, engineered Fc constructs, and chromatographic methods, enabling the creation of complex glycoproteins and FcRn antibodies. Their commitment to precision medicine aims to address unmet medical needs through cutting-edge research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Momenta Pharmaceuticals, Inc. USPTO Patent Assignee Logo
121 Patents

#23 in Cambridge, MA

#181 in Massachusetts

#3,202 in US

#6,623 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Momenta Pharmaceuticals, Inc.

Forward Citations = 766

133 inventors:

goldMedal Carlos J Bosques (35 out of 46 patents)

silverMedal Zachary Shriver (25 out of 85 patents)

bronzeMedal Jonathan C Lansing (16 out of 19 patents)

4.  Nur Sibel Gunay (16 out of 17 patents)

5.  Leona E Ling (15 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Momenta Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/momenta-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…